Pharmacy industry executives requested changes Tuesday to emergency state regulations adopted last month in the wake of the national fungal meningitis outbreak.

Under the new rules, specialty pharmacies similar to New England Compounding Center, the Framingham company whose contaminated drugs are blamed for the outbreak, are required to report to state regulators the volume of medications they are making and whether they have detected contamination in their laboratories.